Today on Outsourcing-Pharma.com   WuXi PharmaTech makes its first acquisition India can dominate global pharma landscape Drug industry spend twice as much on marketing as on R&D Warding off the generic attack Preclinical services news in brief

Related Industry News   New drug target leaves lung cancer cells alone, lonely and dying A drug cocktail to bust brain tumours Mapping the 'human embryome' in BioTime Pfizer buys CovX to bulk biologics pipeline

Breaking News on Outsourcing Pharma
Daily  Monday 07 January 2008		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories WuXi PharmaTech makes its first acquisition WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US... Read India can dominate global pharma landscape Although India 'has carved out a significant portion of the world pharma pie', an enormous change in mindset is needed if the country is to become a global pharmaceutical hub, according to a new report from KPMG... Read Drug industry spend twice as much on marketing as on R&D The pharma industry spends almost twice as much promoting its drugs as it does trying to develop them, according to a new study... Read Warding off the generic attack A recent report has detailed the challenges facing the pharma industry as the generic flood gates open, with the constant advice to start planning early still apparently not heeded by a bewildering number of firms... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Commonwealth Biotechnologies and Stem Cell Sciences... Read
	All News Headlines for: January | December | November
	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here
	Related Industry News New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read A drug cocktail to bust brain tumours A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read Annual round up of all drugs entering Phase I Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007. Read Previous Headlines Galapagos scores first oncology contract Galapagos' services arm has scored another lucrative contract from big pharma - its first in the field of oncology - as it continues to broaden its experience... Read New China:US preclinical partnership formed US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services, as they position themselves to cash in on what is a budding market sector in China... Read More pharmas implicated in Iraq bribery probe While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's... Read IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs... Read Fine Foods extends within pharma Italy's Fine Foods has purchased a domestic contract manufacturer operating in the pharmaceutical arena, extending its presence in this industry... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com